[A retrospective study of 91 injections of botulinus toxin into the upper sphincter of the oesophagus]
- PMID: 15144028
[A retrospective study of 91 injections of botulinus toxin into the upper sphincter of the oesophagus]
Abstract
Objective: To evaluate the results of botulinus toxin in dysphagia arising in the upper sphincter of the oesophagus.
Materials and methods: Since June 1995, 64 patients have had botulinus toxin injected into the upper sphincter of the oesophagus for major swallowing disorders. All cases were treated in the dysphagia service, and underwent clinical assessment, video-swallow screening, and swallowing therapy. The patient cohort included various pathological groups--neurological (vascular accident, head injury, cranial nerve disorders, degenerative diseases), postoperative (surgery for carcinoma of the laryngo-pharynx), and functional, whether purely idiopathic or attributable.
Results and conclusions: Global analysis of the results shows that botulinus toxin has good efficacy in relaxing the upper sphincter of the oesophagus; this does not always lead to recovery of normal swallowing, but can bring about improvement by assisting in the therapeutic management of the swallowing problem, and in improving the dietary intake.
Similar articles
-
Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study.Scand J Gastroenterol. 2008;43(11):1296-303. doi: 10.1080/00365520802245403. Scand J Gastroenterol. 2008. PMID: 18649151 Clinical Trial.
-
Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.Diabetes Care. 2006 Dec;29(12):2650-3. doi: 10.2337/dc05-2486. Diabetes Care. 2006. PMID: 17130199 Clinical Trial.
-
Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation.Neurogastroenterol Motil. 2011 Feb;23(2):139-44, e27-8. doi: 10.1111/j.1365-2982.2010.01604.x. Epub 2010 Oct 1. Neurogastroenterol Motil. 2011. PMID: 20939855
-
Botulinum toxin in neuro-urological disorders.Mov Disord. 2004 Mar;19 Suppl 8:S142-5. doi: 10.1002/mds.20068. Mov Disord. 2004. PMID: 15027067 Review.
-
[Applications of botulin].Duodecim. 2011;127(22):2431-43. Duodecim. 2011. PMID: 22238921 Review. Finnish.
Cited by
-
Efficacy and Safety of Electromyography-Guided Injection of Botulinum Toxin to Treat Retrograde Cricopharyngeus Dysfunction.OTO Open. 2021 Feb 2;5(1):2473974X21989587. doi: 10.1177/2473974X21989587. eCollection 2021 Jan-Mar. OTO Open. 2021. PMID: 33598599 Free PMC article.
-
Retrograde Cricopharyngeal Dysfunction: A Review.J Clin Med. 2024 Jan 11;13(2):413. doi: 10.3390/jcm13020413. J Clin Med. 2024. PMID: 38256547 Free PMC article. Review.
-
The effects of botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness.Eur Arch Otorhinolaryngol. 2013 Mar;270(3):805-15. doi: 10.1007/s00405-012-2114-4. Epub 2012 Aug 4. Eur Arch Otorhinolaryngol. 2013. PMID: 22865104
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical